Nanoquercetin and Extracellular Vesicles as Potential Anticancer Therapeutics in Hepatocellular Carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Raghav, Alok | - |
dc.contributor.author | Jeong, Goo Bo | - |
dc.date.accessioned | 2024-05-06T12:00:29Z | - |
dc.date.available | 2024-05-06T12:00:29Z | - |
dc.date.issued | 2024-04 | - |
dc.identifier.issn | 2073-4409 | - |
dc.identifier.issn | 2073-4409 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/91118 | - |
dc.description.abstract | Despite world-class sophisticated technologies, robotics, artificial intelligence, and machine learning approaches, cancer-associated mortalities and morbidities have shown continuous increments posing a healthcare burden. Drug-based interventions were associated with systemic toxicities and several limitations. Natural bioactive compounds derived nanoformulations, especially nanoquercetin (nQ), are alternative options to overcome drug-associated limitations. Moreover, the EVs-based cargo targeted delivery of nQ can have enormous potential in treating hepatocellular carcinoma (HCC). EVs-based nQ delivery synergistically regulates and dysregulates several pathways, including NF-kappa B, p53, JAK/STAT, MAPK, Wnt/beta-catenin, and PI3K/AKT, along with PBX3/ERK1/2/CDK2, and miRNAs intonation. Furthermore, discoveries on possible checkpoints of anticancer signaling pathways were studied, which might lead to the development of modified EVs infused with nQ for the development of innovative treatments for HCC. In this work, we abridged the control of such signaling systems using a synergetic strategy with EVs and nQ. The governing roles of extracellular vesicles controlling the expression of miRNAs were investigated, particularly in relation to HCC. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | MDPI | - |
dc.title | Nanoquercetin and Extracellular Vesicles as Potential Anticancer Therapeutics in Hepatocellular Carcinoma | - |
dc.type | Article | - |
dc.identifier.wosid | 001200951000001 | - |
dc.identifier.doi | 10.3390/cells13070638 | - |
dc.identifier.bibliographicCitation | CELLS, v.13, no.7 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85190279882 | - |
dc.citation.title | CELLS | - |
dc.citation.volume | 13 | - |
dc.citation.number | 7 | - |
dc.type.docType | Review | - |
dc.publisher.location | 스위스 | - |
dc.subject.keywordAuthor | quercetin nanoparticles | - |
dc.subject.keywordAuthor | extracellular vesicles | - |
dc.subject.keywordAuthor | hepatocellular carcinoma | - |
dc.subject.keywordAuthor | therapeutic targets | - |
dc.subject.keywordAuthor | inhibitors | - |
dc.subject.keywordAuthor | delivery | - |
dc.subject.keywordPlus | TERT PROMOTER MUTATIONS | - |
dc.subject.keywordPlus | PROTEIN-KINASE | - |
dc.subject.keywordPlus | CANCER-CELLS | - |
dc.subject.keywordPlus | GROWTH SUPPRESSION | - |
dc.subject.keywordPlus | SOMATIC MUTATIONS | - |
dc.subject.keywordPlus | SIGNALING PATHWAY | - |
dc.subject.keywordPlus | LIVER-CANCER | - |
dc.subject.keywordPlus | QUERCETIN | - |
dc.subject.keywordPlus | APOPTOSIS | - |
dc.subject.keywordPlus | PROGRESSION | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.